DuPont Launches Liveo™ Pharma TPE Overmolded Assemblies for Pharma and Biopharma Applications

New customizable assemblies help reduce leakage risk, contamination, and in ‑ house assembly time and costs for ultrapure fluid transfer WILMINGTON, Del., April 21, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of DuPont™ Liveo™ Pharma TPE Overmolded Assemblies, engineered for ultrapure fluid transfer across upstream and downstream pharmaceutical and biopharmaceutical processes.